Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
Background and study aim: Dermatological adverse events are an existing concern during treatment of chronic hepatitis C virus infection. Pegylated Interferon (peg –IFN- alfa2a) and ribavirin combination therapy is associated with well-characterized dermatological lesions tending towards a uniform en...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department
2016-06-01
|
| Rangatū: | Afro-Egyptian Journal of Infectious and Endemic Diseases |
| Ngā marau: | |
| Urunga tuihono: | https://aeji.journals.ekb.eg/article_9675_7c62054c8bdb9ded437123f1292263d1.pdf |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|